DR5/TRAIL R2 Protein, Human, Recombinant (His Tag), Biotinylated | 貨號10465-H08H-B

| 代理廠牌: | |
| 原廠連結: | |
| 相關下載: |
DR5/TRAIL R2 Protein, Human, Recombinant (His Tag), Biotinylated | 貨號10465-H08H-B
腫瘤壞死因子受體超家族,成員1b(TNFRSF1B),也稱為死亡受體5,CD262,TNF相關凋亡誘導配體受體2 (TNF-related apoptosis-inducing ligand receptor 2, TRAIL R2),是TNF受體超家族的成員,包含細胞內死亡領域。該受體可以被腫瘤壞死因子相關的凋亡誘導配體(tumor necrosis factor-related apoptosis inducing ligand , TNFSF1 / TRAIL / APO-2L)激活,並轉導凋亡信號。對FADD缺陷小鼠的研究表明,FADD(一種含有銜接蛋白的死亡域)是該蛋白介導的凋亡所必需的。 TRAIL R2 / CD262 / TNFRSF1B作為在兩個不同的人類細胞系表面上可檢測到的TRAIL的唯一受體被獨立純化,該細胞系在受到TRAIL刺激後發生凋亡。 TRAIL R2 / CD262 / TNFRSF1B包含兩個富含胞外半胱氨酸的重複序列,通常是TNF受體(TNFR)家族成員和一個細胞質死亡域。 TRAIL R2 / CD262 / TNFRSF1B通過細胞內銜接子分子FADD / MORT1介導凋亡。 TRAIL受體既可以發出死亡信號,又可以發出基因轉錄信號,其功能讓人想起TNFR1和TRAMP(死亡受體家族的另外兩個成員)的功能。 TRAIL R2 / CD262 / TNFRSF1B中的缺陷可能是引起頭頸部鱗狀細胞癌(neck squamous cell carcinomas , HNSCC)的原因,也被稱為頭頸部鱗狀細胞癌(carcinoma of the head and neck)。
產品描述: TNFRSF10B(NP_003833.3)細胞外結構域(Met1-Glu182)的DNA序列。C端具HIS,純化的蛋白質在體外被生物素化。A DNA sequence encoding the human TNFRSF10B (NP_003833.3) extracellular domain (Met1-Glu182) was expressed with a C-terminal polyhistidine tag. The purified protein was biotinylated in vitro.

Purity
> 95 % as determined by SDS-PAGE.
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
Activity
Testing in progress
Protein Construction
A DNA sequence encoding the human TNFRSF10B (NP_003833.3) extracellular domain (Met1-Glu182) was expressed with a C-terminal polyhistidine tag. The purified protein was biotinylated in vitro.
Accession#
Expressed Host
HEK293 Cells
Species
Human
Predicted N Terminal
Ile 56
Molecule Mass
The recombinant human TNFRSF10B consists of 138 amino acids and predicts a molecular mass of 15.8 kDa.
Formulation
Lyophilized from sterile PBS, pH 7.4
Please contact us for any concerns or special requirements.
Normally 5 % – 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
乾浴加熱水浴槽 | Finnpipette F3 微量分注器 | 試管振盪器 Vortex Mixer | Genereach迷你型微量離心機 | ELISA儀器